Surgical utility of afirma: Effects of high cancer prevalence and oncocytic cell types in patients with indeterminate thyroid cytology

Endocrine Practice

Volumn 20, Issue 4, 2014, Pages 364-369

  Harrell, R MacK ^a   Bimston, David N ^a  

^a affiliation with Nova Southeastern College of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; ASSAY; BENIGN TUMOR; CANCER STAGING; CLINICAL ARTICLE; CYTOPATHOLOGY; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION CLASSIFIER MOLECULAR MARKER ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTIVE VALUE; PREVALENCE; THYROID CANCER; THYROID NODULE; THYROIDECTOMY; PATHOLOGY; THYROID GLAND; THYROID NEOPLASMS;

BIOPSY, FINE-NEEDLE; HUMANS; PREDICTIVE VALUE OF TESTS; PREVALENCE; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY;

EID: 84898647403     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13330.OR     Document Type: Article

References (9)

1. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63:1454-1457.
2. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid. 2009;19:1351-1361.
3. Chudova D, Wilde JI, Wang, ET, et al. Molecular classification of thyroid nodules using the high-dimensionality genomic data. Clin Endocrinol Metab. 2010;95:5296-5304.
4. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 367:705-715.
5. Fletcher, RH. Clinical Epidemiology: The Essentials. 4th ed. Philadephia, PA: Lippincott Williams & Wilkins;2005.
6. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid: Evaluation of 1,020 sequential autopsies. Am J Clin Pathol. 1988:90:72-76.
7. Harach H, Franssila K, Wasenius V. Occult papillary carcinoma of the thyroid: A "normal" finding in Finland. Cancer. 1985;3:531-538.
8. Ganly I, Ricarte Filho J, Eng S, et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013;98:E962-972.
9. Cerutti, JM, Oler, G, Delcelo R, et al. PVALB, a new Hürthle adenoma diagnostic marker identified through gene expression. J Clin Endocrinol Metab. 2011;96:E151-160.